Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, et al
Semaglutide injections are available to people with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher paired with a weight-related health condition such as high blood pressure, type 2 diabetes, obstructive sleep apnea, or high cholesterol levels
If this treatment course continues to show promise and eventually gain widespread medical approval, it could represent a big change in quality of life for patients with type 1 diabetes
Other factors such as gastrointestinal tolerance, cardiovascular history, and personal goals also play a role
For researchers who want structured, expert-reviewed protocols rather than piecing together information from multiple sources, SeekPeptides provides comprehensive protocol guides, dosing calculators, and community support from experienced practitioners who have navigated these exact questions